ConductScience.org, home

Paper486305

Distribution of misonidazole in human tumours and normal tissues.

Ash DV and 2 others. Br J Cancer, 1979. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Distribution of misonidazole in human tumours and normal tissues. Papers, record 486305. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/486305

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Distribution of misonidazole in human tumours and normal tissues.
PubMed
Journal
Br J Cancer
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
3.74
iCite
Revised in PubMed
2019-05-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ash DVD V
2Smith MRM R
3Bugden RDR D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MisonidazoleMajor topic
NeoplasmsMajor topic
NitroimidazolesMajor topic
Brain Neoplasms
Breast Neoplasms
Female
Genital Neoplasms, Female
Humans
Male
Thyroid Diseases
Tissue Distribution
Urinary Bladder Neoplasms

Source PubMed

Download CSV of topics

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1273269Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.Radiat Res1978https://conductscience.org/library/papers/273269PubMed
2444398Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.Br J Cancer1979https://conductscience.org/library/papers/444398PubMed
3659541Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography.J Chromatogr1978https://conductscience.org/library/papers/659541PubMed
4841074Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.Radiology1977https://conductscience.org/library/papers/841074PubMed
5776493Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.Clin Radiol1976https://conductscience.org/library/papers/776493PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
7370171Mitochondrial alterations produced by misonidazole: a study using Amoeba proteus as a single-cell model.Br J Cancer1980https://conductscience.org/library/papers/7370171PubMed
7370170Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.Br J Cancer1980https://conductscience.org/library/papers/7370170PubMed
7370166Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.Br J Cancer1980https://conductscience.org/library/papers/7370166PubMed
7295516Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.Br J Cancer1981https://conductscience.org/library/papers/7295516PubMed
7248155Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers.Br J Cancer1981https://conductscience.org/library/papers/7248155PubMed
7225285The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.Br J Cancer1981https://conductscience.org/library/papers/7225285PubMed
7190019Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.Br J Cancer1980https://conductscience.org/library/papers/7190019PubMed
7172406Absorption and distribution of vaginally administered misonidazole.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7172406PubMed
7059476The penetration of misonidazole into a mature structural cartilage.Br J Cancer1982https://conductscience.org/library/papers/7059476PubMed
7016157A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.Br J Cancer1981https://conductscience.org/library/papers/7016157PubMed
7013776Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S.Br J Cancer1981https://conductscience.org/library/papers/7013776PubMed
6932924Growth delay studies in patients with multiple metastases.Br J Cancer Suppl1980https://conductscience.org/library/papers/6932924PubMed
3719893Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3719893PubMed
3677296Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3677296PubMed
2757919Microscopic distribution of misonidazole in mouse tissues.Br J Cancer1989https://conductscience.org/library/papers/2757919PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/486305

GET https://conductscience.org/api/papers/v1/486305/authors